Clinical Trials Browser

Phase 2 × carmustine, poliferprosan 20 drug combination × 90 days × Clear all

NCT04222062 2026-04-28

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Phase 2 Recruiting

Brain Neoplasms